Monday’s Midday Stock Update: Goodrich Petroleum (GDP), Macy’s (M), Cleveland-Cliffs (CLF), TG Therapeutics (TGTX), Sea (SE)

By Carrie Williams

So far Monday, August 10, NASDAQ is down -2.25% and the S&P is up 0.05%. Here are this morning’s most active stocks: Goodrich Petroleum (GDPResearch Report), Macy’s (MResearch Report), Cleveland-Cliffs (CLFResearch Report), TG Therapeutics (TGTXResearch Report) and Sea (SEResearch Report).

Goodrich Petroleum is down -11.02% in midday trading to $7.99. Shares opened today at $8.98. The company has a 52-week low of $2.40 and a 52-week high of $11.80. On the Street’s front, the average 12-month analyst price target for the stock is $10.00, marking a 11.36% potential upside from current levels. In a report issued on July 19, Northland Securities analyst Jeff Grampp maintained a Buy rating on GDP, with a price target of $10.00, which represents a potential upside of 11% from where the stock is currently trading.

Macy’s is up 9.01% in midday trading to $7.26. Shares opened today at $6.66. The company has a 52-week low of $4.38 and a 52-week high of $20.25. On the Street’s front, the average 12-month analyst price target for the stock is $5.17, marking a -22.37% potential downside from current levels. In a report issued on July 22, UBS analyst Jay Sole downgraded M to Sell, with a price target of $3.00, which implies a downside of 55% from current levels. Separately, on July 2, Deutsche Bank’s Paul Trussell maintained a Hold rating on the stock and has a price target of $6.00.

Cleveland-Cliffs is up 7.93% in midday trading to $5.99. Shares opened today at $5.55. The company has a 52-week low of $2.63 and a 52-week high of $9.02. On the Street’s front, the average 12-month analyst price target for the stock is $5.65, marking a 1.80% potential upside from current levels. In a report issued on July 31, GLJ Research analyst Gordon Johnson downgraded CLF to Sell, with a price target of $2.51, which represents a potential downside of 55% from where the stock is currently trading. Separately, on the same day, Credit Suisse’s Curt Woodworth maintained a Hold rating on the stock and has a price target of $4.75.

See today’s analyst top recommended stocks >>

TG Therapeutics is down -7.76% in midday trading to $19.01. Shares opened today at $20.61. The company has a 52-week low of $4.95 and a 52-week high of $24.76. On the Street’s front, the average 12-month analyst price target for the stock is $43.00, marking a 108.64% potential upside from current levels. In a report issued on June 17, H.C. Wainwright analyst Edward White maintained a Buy rating on TGTX, with a price target of $32.00, which implies an upside of 55% from current levels. Over the last 3 months, the insider sentiment on TG Therapeutics has been negative based on 14 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Sea is down -7.4% in midday trading to $122.84. Shares opened today at $132.66. The company has a 52-week low of $26.41 and a 52-week high of $146.99. On the Street’s front, the average 12-month analyst price target for the stock is $103.70, marking a -21.83% potential downside from current levels. In a report issued on July 8, Merrill Lynch analyst Paul Dewberry maintained a Buy rating on SE, with a price target of $135.00, which represents a slight upside potential from current levels. Separately, on May 18, Stifel Nicolaus’ Scott Devitt maintained a Hold rating on the stock and has a price target of $68.00.

Trending Stocks Based on Insider Activity >>